User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

Search results

  1. Scientific highlights: 4th European – Middle East forum on cardiovascular risks

    ... prevalence of renal hypertension is approximately 5%. Spironolactone/eplerenone are the most effective additional drugs to treat ... progress warfarin was withdrawn with apixabant and spironolactone added. He was discharged from hospital with atrial fibrillation ...

  2. Resistant hypertension

    ... in a randomized, double-blind trial (ASPIRANT), 25 mg/day spironolactone reduced 24-hour blood pressure by 10 mmHg compared with placebo ... hypertension. 20 An α-blocker is an alternative to spironolactone, particularly in patients undergoing screening for primary ...

  3. Congress Report: European Society of Cardiology (ESC) 2015

    ... blockers Calcium channel blockers Diuretics Spironolactone Bisoprolol Doxazosin PARAMETER study Hypertension in ... blockers, calcium channel blockers and diuretics). Either spironolactone or a choice of bisoprolol or doxazosin was added to this ...

  4. Scientific Highlights: 2016 Latin American conference on cardiometabolic diseases management: health emergencies in focus

    ... findings strongly support lowering SBP to <130 mmHg, with spironolactone emerging as the most effective antihypertensive (Table 3). ... showed an inverse correlation with the BP lowering effect of spironolactone. Table 3. PATHWAY-2 showed the antihypertensive effects of ...

  5. Separating resistant hypertension from hypertension

    ... to achieve blood pressure control. 8 Add low dose spironolactone (25 mg daily) to multidrug treatment regimens. 8 If these ... Nishizaka Mk, et al . Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens ...

  6. Highlights from the European Society of Cardiology (ESC) Congress, Munich, Germany, 25–29 August, 2018

    ... treatment was the triple combination pill along with spironolactone or another diuretic, an alpha-blocker or a beta-blocker. ...

  7. Scientific Highlights: 2015 Latin American conference on cardiometabolic diseases management

    ... causes and the treatment approach. [1, 2] Spironolactone, hemodynamic treatment, baroreflex activation therapy [3] ...